Table 2.
Regression analysis of food-specific IgG and various healthy outcomes
| Health outcomes | Odds ratio (95% CI)) | p value | Adjusted odds ratio | p value |
|---|---|---|---|---|
| (95% CI)) | ||||
| Overweight | 0.81 (0.78–0.85) | < 0.001 | 0.92 (0.87–0.96) | < 0.001 |
| Central obesity | 0.87 (0.83–0.91) | < 0.001 | 0.99 (0.94–1.04) | 0.59 |
| Dyslipidemia | 0.86 (0.82–0.90) | < 0.001 | 0.96 (0.91–1.0) | 0.07 |
| Hypercholesterolemia | 0.89 (0.85–0.94) | < 0.001 | 0.95 (0.90–1.0) | 0.07 |
| Hypertriglyceridemia | 0.79 (0.75–0.83) | < 0.001 | 0.87 (0.83–0.92) | < 0.001 |
| Low HDL-C | 0.90 (0.81–1.0) | 0.04 | 0.98 (0.88–1.09) | 0.65 |
| Pathoglycemia | 0.83 (0.77–0.89) | < 0.001 | 0.93 (0.87–0.99) | 0.03 |
| Hyperuricemia | 0.91 (0.86–0.96) | 0.001 | 1.06 (0.99–1.13) | 0.1 |
| Dysarteriotony | 0.86 (0.81–0.91) | < 0.001 | 0.98 (0.92–1.04) | 0.47 |
| Abnormal SBP | 0.87 (0.81–0.93) | < 0.001 | 098 (0.91–1.05) | 0.53 |
| Abnormal DBP | 0.83 (0.87–0.88) | < 0.001 | 0.93 (0.87–1.0) | 0.05 |
| Anemia | 1.23 (1.11–1.45) | 0.001 | 1.15 (1.01–1.33) | 0.05 |
| Abnormal liver function | 0.85 (0.81–0.89) | < 0.001 | 0.98 (0.92–1.04) | 0.47 |
| Fatty liver disease | 0.83 (0.79–0.81) | < 0.001 | 0.96 (0.90–1.03) | 0.28 |
| Thyroid disease | 1.10 (1.05–1.16) | < 0.001 | 1.09 (1.04–1.15) | 0.001 |
Adjusted for age, sex, BMI (except BMI-specific models), waistline (except waistline-specific models), blood pressure (except BP-specific models), blood lipid (except blood lipid specific models), FBG (except FBG-specific models). Fatty liver and uric acid were also introduced as covariates in the model with liver function as outcomes. Complete covariate data available for 10,637 person examinations
CI, confidence interval; BP, blood pressure; HDL-C, high density lipoprotein cholesterol; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; FBG, fasting blood-glucose